249
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Validated Register-Based Algorithm to Identify Patients Diagnosed with Recurrence of Surgically Treated Stage I Lung Cancer in Denmark

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 251-261 | Received 14 Nov 2022, Accepted 15 Feb 2023, Published online: 01 Mar 2023

References

  • Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1474–5488.
  • The Danish National Board of Health [Homepage on the internet]. Cancer incidence in Denmark 2019 (in Danish); 2021. Available from: https://sundhedsdatastyrelsen.dk/da/find-tal-og-analyser/tal-og-analyser/sygdomme-og-behandlinger/kraeft/kraeft_nyetilfaelde_aarsrapport. Accessed October 17, 2022.
  • Leduc C, Antoni D, Charloux A, Falcoz PE, Quoix E. Comorbidities in the management of patients with lung cancer. Eur Respir J. 2017;49(3):1601721.
  • The Danish Lung Cancer group, The Danish Lung Cancer Register [Homepage on the internet]. Danish lung cancer register - annual national report 2019–2020 (in Danish); 2021. Available from: https://www.lungecancer.dk/wp-content/uploads/2021/10/%C3%85rsrapport-20192020_netudgave.pdf. Accessed October 17, 2022.
  • Subotic D, Van Schil P, Grigoriu B. Optimising treatment for post-operative lung cancer recurrence. Eur Respir J. 2016;47(2):374–378.
  • Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting lung and colorectal cancer recurrence using structured clinical/administrative data to enable outcomes research and population health management. Med Care. 2017;55(12):e88–e98.
  • Hassett MJ, Ritzwoller DP, Taback N, et al. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014;52(10):e65–e73.
  • Takenaka T, Tagawa T, Kohno M, et al. Consideration of the optimal surgical procedure based on the risk of recurrence in clinical stage 0 or IA lung adenocarcinoma. Anticancer Res. 2022;42(2):1137–1142.
  • Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst. 2015;107(8):djv134–djv134.
  • Izci H, Tambuyzer T, Tuand K, et al. A systematic review of estimating breast cancer recurrence at the population level with administrative data. J Natl Cancer Inst. 2020;112(10):djaa050.
  • Uno H, Ritzwoller DP, Cronin AM, Carroll NM, Hornbrook MC, Hassett MJ. Determining the time of cancer recurrence using claims or electronic medical record data. JCO Clin Cancer Inform. 2018;2(2):1–10.
  • Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210–2215.
  • Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P. A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark. Clin Epidemiol. 2018;10:1755–1763.
  • Rasmussen LA, Jensen H, Flytkjær Virgilsen L, Jellesmark Thorsen LB, Vrou Offersen B, Vedsted P. A validated algorithm for register-based identification of patients with recurrence of breast cancer—based on Danish Breast Cancer Group (DBCG) data. Cancer Epidemiol. 2019;59:129–134.
  • Rasmussen LA, Jensen H, Virgilsen LF, et al. Identification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries. Acta Oncol. 2021;60(4):1–7.
  • Rasmussen LA, Jensen H, Virgilsen LF, Hölmich LR, Vedsted P. A validated register-based algorithm to identify patients diagnosed with recurrence of malignant melanoma in Denmark. Clin Epidemiol. 2021;13:207–214.
  • Pedersen RN, Öztürk B, Mellemkjær L, et al. Validation of an algorithm to ascertain late breast cancer recurrence using Danish medical registries. Clin Epidemiol. 2020;12:1083–1093.
  • Cronin-Fenton D, Kjærsgaard A, Nørgaard M, et al. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark. Breast Cancer Res Treat. 2018;167(2):517–528.
  • Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22–25.
  • Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39(7_suppl):42–45.
  • Sandegaard JL, Schmidt SAJ, Sørensen HT, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
  • Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish national pathology registry and data bank. Clin Epidemiol. 2010;2:51–56.
  • SNOMED international [Homepage on the internet]. SNOMED international. Available from: https://www.snomed.org/. Accessed October 17, 2022.
  • Christensen NL, Dalton SO, Mellemgaard A, Christensen J, Kejs AMT, Rasmussen TR. Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence? Acta Oncol. 2018;57(11):1556–1560.
  • Christensen NL, Jekunen A, Heinonen S, Dalton DO, Rasmussen TR. Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison. Acta Oncol. 2017;56(7):943–948.
  • Union for International Cancer Control [Homepage on the internet]. TNM classification of malignant tumours; 2018. Available from: https://www.uicc.org/resources/tnm. Accessed October 17, 2022.
  • McBride GB. A Proposal for Strength of Agreement Criteria for Lin’s Concordance Correlation Coefficient. Hamilton, New Zealand: National Institute of Water & Atmospheric Reseach; 2005.
  • Winther-Larsen A, Hoffmann L, Moeller DS, Khalil AA, Knap MM. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy. Acta Oncol. 2015;54(9):1574–1581.
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591.
  • Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2020–2026.
  • Rothmann KJ, Greenland S, Lash TL. Modern Epidemiology. Third ed. Wolters Kluwer: Lippincott Williams & Wilkins; 2008.
  • Hewitt ME, Greenfield S, Stovall E. From Cancer Patient to Cancer Survivor: Lost in Transition. (Press NA, ed.). The National Academies Press; 2006.
  • Ministry of the Interior and Health of Denmark. Law information (In Danish: retsinformation). Available from: https://www.retsinformation.dk/eli/lta/2020/1338. Accessed February 10, 2023.